A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients

Exclusion Criteria

• •1. History or presence of other concomitant liver diseases
• •2. Patients with laboratory values indicative of hepatic decompensation or significant hepatobiliary injury
• •3. History of liver transplant
• •4. Evidence of OCA, fenofibrate, or bezafibrate use
• •5. History or presence of hepatic decompensating events
• •6. Participation in a clinical trial for a PBC medication